BlackRock Inc. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$608,000
-87.9%
1,267,370
-66.1%
0.00%
Q1 2019$5,011,000
+15.8%
3,738,193
-2.4%
0.00%
Q4 2018$4,328,000
-63.7%
3,830,381
-11.3%
0.00%
-100.0%
Q3 2018$11,914,000
-20.0%
4,316,258
+3.4%
0.00%0.0%
Q2 2018$14,895,000
+20.6%
4,172,314
+3.7%
0.00%0.0%
Q1 2018$12,350,000
-51.5%
4,022,448
-0.5%
0.00%0.0%
Q4 2017$25,479,000
+11.6%
4,044,340
+21.2%
0.00%0.0%
Q3 2017$22,825,000
+35.2%
3,337,044
+40.9%
0.00%0.0%
Q2 2017$16,888,000
-20.1%
2,368,538
+2.9%
0.00%0.0%
Q1 2017$21,143,000
+70376.7%
2,300,699
+30116.7%
0.00%
Q4 2016$30,000
-6.2%
7,614
-7.9%
0.00%
Q3 2016$32,000
-8.6%
8,2670.0%0.00%
Q2 2016$35,000
+191.7%
8,267
+227.5%
0.00%
Q1 2016$12,000
-63.6%
2,524
-24.0%
0.00%
Q4 2015$33,000
+175.0%
3,320
+112.0%
0.00%
Q3 2015$12,000
-76.5%
1,566
+46.1%
0.00%
Q2 2015$51,000
+104.0%
1,072
+56.3%
0.00%
Q1 2015$25,000
+8.7%
686
+18.5%
0.00%
Q4 2014$23,000
+91.7%
5790.0%0.00%
Q3 2014$12,000
+50.0%
5790.0%0.00%
Q2 2014$8,000
+33.3%
579
+9.9%
0.00%
Q1 2014$6,000
+20.0%
527
+39.4%
0.00%
Q4 2013$5,0003780.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2016
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders